August 30, 2016 4:13 PM ET

Healthcare Equipment and Supplies

Company Overview of Acelity L.P. Inc.

Company Overview

Kinetic Concepts Inc. produces surgical healing and hospital patient-mobility equipment, including a tissue-repair therapy used in hospitals in the U.S. and worldwide for acute care and serious trauma. Its wound-care and tissue-repair system is used in pulmonary care, for post-cardiac-arrest complications in the intensive-care unit, and for other types of wound treatment including failed surgical closures, amputations, and serious pressure ulcers. The system works by using a vacuum-assisted closure technology. A second product is a line of hospital equipment that provides mobility to patients who cannot move because of pulmonary complications or due to obesity. Its bariatric-care products pr...

12930 West Interstate 10

San Antonio, TX 78249

United States

Founded in 1976

5,800 Employees

Phone:

210-524-9000

Key Executives for Acelity L.P. Inc.

Chief Executive Officer, President and Director
Age: 50
Chief Financial Officer and Executive Vice President
Age: 53
Senior Vice President of Operations, Quality & Regulatory
Age: 57
President of Developed Markets
Age: 46
Group President of Businesses & Innovation
Age: 42
Compensation as of Fiscal Year 2016.

Acelity L.P. Inc. Key Developments

Acelity Introduces New Product

Acelity has introduced a new product nationally that will make it less painful for patients to change their wound dressings. The Biosorb Gelling Fiber Dressing forms a gel when it comes into contact with an open wound. The gel offers increased absorbency and holds its shape, which allows for intact removal of the dressing. It can be used on a wide range of open wounds, such as leg ulcers, pressure ulcers, diabetic foot ulcers, open surgical wounds, partial thickness burns, traumatic wounds and cancer-related wounds. Such chronic and surgical wounds affect more than 10.5 million people in the United States and Europe. The Biosorb product also will be available in Europe in the coming months. Acelity, which employs 1,500 people at its San Antonio headquarters, specializes in advanced wound care and regenerative medicine.

Acelity L.P. Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016

Acelity L.P. Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, total revenues were $472,421,000 against $461,645,000 last year. Operating earnings were $80,439,000 against $90,170,000 last year. Loss before income tax benefit was $30,866,000 against $24,855,000 last year. Net loss was $20,115,000 against $17,631,000 last year. This increase was primarily due to the loss on debt extinguishment of $10.1 million and professional fees of $6.9 million associated with debt transactions in the second quarter of 2016, partially offset by foreign currency gains. Adjusted EBITDA was $171,103,000 against $172,890,000 last year. The decline in Adjusted EBITDA was attributable to investments being made in franchise structure and sales force to drive growth, partially offset by revenue growth and expense savings associated with integration and business optimization efforts. For the six months, total revenues were $923,787,000 against $905,695,000 last year. Operating earnings were $157,707,000 against $174,310,000 last year. Loss before income tax benefit was $70,664,000 against $29,242,000 last year. Net loss was $46,090,000 against $22,162,000 last year. Net cash used by operating activities was $39,579,000 against $4,004,000 last year. Additions to property, plant and equipment was $35,762,000 against $29,574,000 last year. Adjusted EBITDA was $332,116,000 against $338,726,000 last year. The decline in cash flow from operating activities were primarily driven by lower operating earnings, increased networking capital and higher annual incentive payouts related to the company's improved financial performance in 2015 that were paid out in the first quarter of this year.

Acelity L.P. Inc. to Report Q2, 2016 Results on Aug 02, 2016

Acelity L.P. Inc. announced that they will report Q2, 2016 results at 1:42 PM, GMT Standard Time on Aug 02, 2016

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 1, 2015
Spiracur Inc., SNaP® Therapy System
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acelity L.P. Inc., please visit www.acelity.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.